A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: Blood-derived endothelial progenitor cells

Stem Cells Translational Medicine

Volumn 1, Issue 12, 2012, Pages 855-865

  Geti, Imbisaat ^a   Ormiston, Mark L ^a   Rouhani, Foad ^a   Toshner, Mark ^a   Movassagh, Mehregan ^a   Nichols, Jennifer ^a   Mansfield, William ^a   Southwood, Mark ^a   Bradley, Allan ^b   Rana, Amer Ahmed ^a   Vallier, Ludovic ^a   Morrell, Nicholas W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Direct cell conversion; Endothelial cell; Induced pluripotent stem cells; Progenitor cells; Reprogramming

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CD14 ANTIGEN; CD146 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN RETRIEVAL; ARTICLE; CELL ISOLATION; CELL KINETICS; CELL LINE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; KARYOTYPE; MALE; MICROSCOPY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PROTEIN METHYLATION; PULMONARY HYPERTENSION; PYROSEQUENCING; SKIN FIBROBLAST; TERATOMA; ADULT; ADULT STEM CELL; ANIMAL; CANCER TRANSPLANTATION; CELL DIFFERENTIATION; CELL LINEAGE; CULTURE TECHNIQUE; CYTOLOGY; HEMATOPOIETIC STEM CELL; KARYOTYPING; METHODOLOGY; MONONUCLEAR CELL; MOUSE MUTANT; NUCLEAR REPROGRAMMING; PATHOLOGY; PHYSIOLOGY; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIUM;

ADULT; ADULT STEM CELLS; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINEAGE; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KARYOTYPING; LEUKOCYTES, MONONUCLEAR; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NUCLEAR REPROGRAMMING; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TERATOMA;

MLCS; MLOWN;

EID: 84872920388     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0093     Document Type: Article

References (36)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
2. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872.
3. Hussein SM, Batada NN, Vuoristo S et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011;471:58-62.
4. Martins-Taylor K, Nisler BS, TaapkenSMet al. Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol 2011;29:488-491.
5. Yusa K, Rashid ST, Strick-Marchand H et al. Targeted gene correction of _1-antitrypsin deficiency in induced pluripotent stem cells. Nature 2011;478:391-394.
6. Loh YH, Agarwal S, Park IH et al. Generation of induced pluripotent stem cells from human blood. Blood 2009;113:5476-5479.
7. Ye Z, Zhan H, Mali P et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 2009;114:5473-5480.
8. Seki T, Yuasa S, Oda M et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010;7:11-14.
9. Loh YH, Hartung O, Li H et al. Reprogramming of T cells from human peripheral blood. Cell Stem Cell 2010;7:15-19.
10. Staerk J, Dawlaty MM, Gao Q et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 2010;7:20-24.
11. Chou BK, Mali P, Huang X et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 2011;21:518-512.
12. Okabe M, Otsu M, Ahn DH et al. Definitive proof for direct reprogramming of hematopoietic cells to pluripotency. Blood 2009; 114:1764-1767.
13. Eminli S, Foudi A, Stadtfeld M et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 2009;41:968-976.
14. Haase A, Olmer R, Schwanke K et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 2009;5:434-441.
15. Ho PJ, Yen ML, Lin JD et al. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2: Brief report. Arterioscler Thromb Vasc Biol 2010;30:1905-1907.
16. Panopoulos AD, Ruiz S, Yi F et al. Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cells. PLoS One 2011;6:e19743.
17. Mack AA, Kroboth S, Rajesh D et al. Generation of induced pluripotent stem cells from CD34_cells across blood drawn from multiple donors with non-integrating episomal vectors. PLoS One 2011;6:e27956.
18. Chou BK, Mali P, Huang X et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 2011;21:518-529.
19. Hu K, Yu J, Suknuntha K et al. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 2011;117:e109-e119.
20. Lin Y, Weisdorf DJ, Solovey A et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-77.
21. Medina R, O'Neill CL, Humphreys MW et al. Outgrowth endothelial cells: Characterization and their potential for reversing ischemic retinopathy. Invest Ophthalmol Vis Sci 2010;51:5906-5913.
22. Yoder M, Mead LE, Prater D et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109: 1801-1809.
23. Piaggio G, Rosti V, Corselli M et al. Endothelial colony forming cells (ECFCs) from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker. Blood 2009;114:3127-3130.
24. Vallier L, Touboul T, Brown S et al. Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. STEM CELLS 2009;27:2655-2666.
25. Machado RD et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 2000;26:81-84.
26. Laurent LC, Ulitsky I, Slavin I et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011;8:106-118.
27. Liang Q, Conte N, Skarnes WC et al. Extensive genomic copy number variation in embryonic stem cells Proc Natl Acad Sci USA 2008; 105:17453-17456.
28. International Stem Cell Initiative, Amps K, Andrews PW et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 2011;29: 1132-1144.
29. de Cid R, Riveira-Munoz E, Zeeuwen PL et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 2009;41:211-215.
30. Imamura H, Ohta T, Tsunetoshi K et al. Transdifferentiation of bone marrow-derived endothelial progenitor cells into the smooth muscle cell lineage mediated by transforming growth factor-beta1. Atherosclerosis 2010; 211:114-121.
31. Medici D, Shore EM, Lounev VY et al. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 2010;16: 1400-1406.
32. Wylie-Sears J, Aikawa E, Levine RA et al. Mitral valve endothelial cells with osteogenic differentiation potential. Arterioscler Thromb Vasc Biol 2011;31:598-607.
33. Tran KV, Gealekman O, Frontini A et al. The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells. Cell Metab 2012;15:222-229.
34. Gupta RK, Mepani RJ, Kleiner S et al. Zfp423 expression identifies committed preadipocytesand localizes to adipose endothelial and perivascular cells. Cell Metab 2012;15:230-239.
35. Warren L, Manos PD, Ahfeldt T. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010;7: 618-630.
36. Okita K, Matsumura Y, Sato Y et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 2011;8:409-412.